Scientists use gold nanoparts that act as missiles seeking tumor to target prostate cancer, in a first clinical trial of a type.
The nanoparticles, or nanoshells, are made from small layers of silica glass formed into a sffer and wrapped in a thin layer of gold.
The shells look for cancerous and saturated cells, and then their higher vibrational properties are harnessed to cause tumor tissue to a pulse with extreme temperature when light is used by a specifically designed laser to excite particles.
The oscillation kills the cancer cells while keeping the healthy tissue, avoiding the nerves and urinary sphincter.
The trials are underway at Icahn School of Medicine in Mount Sinai, and the University of Michigan to test the effectiveness of the therapy.